← 返回专利悬崖列表

Netarsudil Dimesylate
Tier C · 观察 / 贸易Netarsudil Dimesylate
Aerie Pharmaceuticals Inc
原研
2017
首批上市
-
到期年(公开口径)
$0.08B ▲
峰值销售
化学药
类型
靶点:ROCKs、NET
商品名:Rhopressa
适应症(已批准):高眼压、开角型青光眼
各地区研发/上市状态
美国
批准上市
2017-12-18
欧盟
批准上市
2019-11-19
中国
-
日本
无进展
2020-11-30
合成路线与中间体2 routes
原研路线 × 1优化路线(非专利)× 1工艺路线 × 0
路线按「原研路线 → 优化路线 / 工艺路线(非专利)」排序。每条路线附本站自绘的路线流程图(中间体 → 原料药)与中间体表(编号 / CAS / 英文名),可直接用于供应商开发与询价。流程图由本站依据已授权的结构化数据自行渲染,未使用任何第三方路线图。
原研Route 1步骤 11 · 总收率 /

| 编号 | CAS 号 | 中间体名称 |
|---|---|---|
| NETA-001 | 73401-74-8 | 2-(4-(hydroxymethyl)phenyl)acetic acid |
| NETA-002 | 18107-18-1 | (diazomethyl)trimethylsilane |
| NETA-003 | 155380-11-3 | methyl 2-[4-(hydroxymethyl)phenyl]acetate |
| NETA-004 | 1253955-08-6 | methyl 2-(4-(hydroxymethyl)phenyl)acetate |
| NETA-005 | 5332-26-3 | methyl 2-(4-(((triisopropylsilyl)oxy)methyl)phenyl)acetate |
| NETA-006 | 1253955-09-7 | 2-(bromomethyl)isoindoline-1,3-dione |
| NETA-007 | 1253955-10-0 | methyl 3-(1,3-dioxoisoindolin-2-yl)-2-(4-(((triisopropylsilyl)oxy)methyl)phenyl)propanoate |
| NETA-008 | 23687-26-5 | 2-((2-carboxy-2-(4-(((triisopropylsilyl)oxy)methyl)phenyl)ethyl)carbamoyl)benzoic acid |
| NETA-009 | 1253955-11-1 | isoquinolin-6-amine |
| NETA-010 | 1253955-12-2 | 3-(1,3-dioxoisoindolin-2-yl)-N-(isoquinolin-6-yl)-2-(4-(((triisopropylsilyl)oxy)methyl)phenyl)propanamide |
| NETA-011 | 1253955-13-3 | 3-amino-N-(isoquinolin-6-yl)-2-(4-(((triisopropylsilyl)oxy)methyl)phenyl)propanamide |
| NETA-012 | 1253955-14-4 | tert-butyl (3-(isoquinolin-6-ylamino)-3-oxo-2-(4-(((triisopropylsilyl)oxy)methyl)phenyl)propyl)carbamate |
| NETA-013 | 611-01-8 | 2,4-dimethylbenzoic acid |
| NETA-014 | 1253955-17-7 | 4-(3-((tert-butoxycarbonyl)amino)-1-(isoquinolin-6-ylamino)-1-oxopropan-2-yl)benzyl 2,4-dimethylbenzoate |
| NETA-015 | 1253955-19-9 | (S)-4-(3-((tert-butoxycarbonyl)amino)-1-(isoquinolin-6-ylamino)-1-oxopropan-2-yl)benzyl 2,4-dimethylbenzoate |
优化Route 2步骤 7 · 总收率 /

| 编号 | CAS 号 | 中间体名称 |
|---|---|---|
| NETA-003 | 155380-11-3 | methyl 2-[4-(hydroxymethyl)phenyl]acetate |
| NETA-008 | 23687-26-5 | 2-((2-carboxy-2-(4-(((triisopropylsilyl)oxy)methyl)phenyl)ethyl)carbamoyl)benzoic acid |
| NETA-015 | 1253955-19-9 | (S)-4-(3-((tert-butoxycarbonyl)amino)-1-(isoquinolin-6-ylamino)-1-oxopropan-2-yl)benzyl 2,4-dimethylbenzoate |
| NETA-016 | 1253955-08-6 | methyl 2-(4-(hydroxymethyl)phenyl)acetate |
| NETA-017 | 611-01-8 | 2,4-dimethylbenzoic acid |
| NETA-018 | 2097334-15-9 | 4-(2-methoxy-2-oxoethyl)benzyl 2,4-dimethylbenzoate |
| NETA-019 | 183072-03-9 | (R)-5-benzyloxazolidin-2-one |
| NETA-020 | - | (R)-4-(2-(5-benzyl-2-oxooxazolidin-3-yl)-2-oxoethyl)benzyl 2,4-dimethylbenzoate |
| NETA-021 | 305860-41-7 | tert-butyl ((1H-benzo[d][1,2,3]triazol-1-yl)methyl)carbamate |
| NETA-022 | - | 4-((S)-1-((R)-5-benzyl-2-oxooxazolidin-3-yl)-3-((tert-butoxycarbonyl)amino)-1-oxopropan-2-yl)benzyl 2,4-dimethylbenzoate |
| NETA-023 | 2097334-20-6 | (S)-3-((tert-butoxycarbonyl)amino)-2-(4-(((2,4-dimethylbenzoyl)oxy)methyl)phenyl)propanoic acid |
| NETA-024 | 66270-36-8 | 1,1,1-trichloro-2-methylpropan-2-yl carbonochloridate |
常见问题(FAQ)
Netarsudil Dimesylate的适应症有哪些?
已批准的适应症包括:高眼压、开角型青光眼。
Netarsudil Dimesylate的专利什么时候到期?
Netarsudil Dimesylate的专利到期年暂无公开口径,本页会在数据管道核实后更新。
Netarsudil Dimesylate有几条合成路线?
本站收录 2 条合成路线,最短路线 7 步、总收率 /。每条路线的中间体均带登记编号与 CAS 号。
Netarsudil Dimesylate的关键中间体在哪里可以采购?
Netarsudil Dimesylate路线中的中间体均已建立 CAS 档案,可直接按 CAS 发起询价,需求会进入供应网络撮合池。
如何获取Netarsudil Dimesylate中间体的报价?
在本页选择目标中间体的 CAS 进入档案页,或在询价页直接提交需求;CAS 会自动带入供需撮合流程,由供应网络反馈报价。
数据来源:多源数据交叉核实(仅结构化字段) · 2026-09-24